Recent research highlights the role of sensory nerves in promoting breast cancer metastasis. By secreting neuropeptides, these nerves enhance tumor growth and spread, revealing a potential new therapeutic target. The study shows that the FDA-approved drug aprepitant can inhibit this pathway, reducing metastasis in breast cancer models. This breakthrough underscores the critical link between the nervous system and cancer, offering new avenues for treatment.